ClinicalTrials.gg
Not yet recruitingNCT07795931IncontinenceUpdated Sep 25, 2026

Comparison of Home Versus Clinic Kegel Rehabilitation in Women With Urinary Incontinence in the Tabuk Region

An interventional study of Home -Based Kegel Trainer Exercises (Kegel Trainer Application) will be used by the participants at home for training the pelvic floor muscles over 9 levels. and Clinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months in Urinary Incontinence (UI), sponsored by University of Tabuk. Not yet recruiting at 1 site in Saudi Arabia. Open to female participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by University of Tabuk · Not applicable, Interventional, and Treatment

Updated Sep 25, 2026Start date movedPrimary completion moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
Female
01

Study summary

Urinary incontinence is a common condition among women that significantly affects physical health, emotional well-being, social participation, and overall quality of life. Pelvic floor muscle training recommended as the first-line conservative treatment for urinary incontinence. While clinic-based rehabilitation provides direct supervision by healthcare professionals, home-based Kegel exercise programs offer greater convenience and accessibility. However, limited evidence exists regarding the comparative effectiveness of these approaches among women in Saudi Arabia.

The study aims to compare the effectiveness of home-based Kegel exercises and clinic-based rehabilitation programs in improving pelvic floor muscle strength, reducing urinary incontinence symptoms, and enhancing quality of life among women with urinary incontinence in the Tabuk region.

This study will employ a randomized controlled trial (RCT) design. Eligible women diagnosed with urinary incontinence will be recruited from the Maternity and Children Hospital, Tabuk. Participants will be randomly assigned to one of two groups:

  • Group A: Home-based Kegel exercise program.
  • Group B: Supervised clinic-based pelvic floor rehabilitation program. Both interventions will be conducted over a 12-week period. Outcome Measures

The effectiveness of the interventions will be evaluated using:

  • Perineometer measurements to assess pelvic floor muscle strength.
  • Pad Test to assess urinary leakage severity.
  • King's Health Questionnaire (KHQ) to evaluate quality of life.
  • Adherence records to monitor compliance with the exercise program. The assessments will be conducted at baseline, week 8, and week 12.
Read the detailed description

Background Urinary incontinence (UI) is a common condition among women that significantly affects physical health, emotional well-being, social participation, and overall quality of life. Pelvic floor muscle training (PFMT) is widely recommended as the first-line conservative treatment for urinary incontinence. While clinic-based rehabilitation provides direct supervision by healthcare professionals, home-based Kegel exercise programs offer greater convenience and accessibility. However, limited evidence exists regarding the comparative effectiveness of these approaches among women in Saudi Arabia.

Aim The study aims to compare the effectiveness of home-based Kegel exercises and clinic-based rehabilitation programs in improving pelvic floor muscle strength, reducing urinary incontinence symptoms, and enhancing quality of life among women with urinary incontinence in the Tabuk region.

Objectives

  1. To evaluate the effectiveness of home-based Kegel exercises in women with urinary incontinence.
  2. To evaluate the effectiveness of clinic-based pelvic floor rehabilitation.
  3. To compare outcomes between both intervention approaches.
  4. To compare the outcomes of both interventions regarding pelvic floor muscle strength, urinary leakage, and quality of life.
  5. To assess participants' adherence to the prescribed exercise programs. Methodology

This study will employ a randomized controlled trial (RCT) design. Eligible women diagnosed with urinary incontinence will be recruited from the Maternity and Children Hospital, Tabuk. Participants will be randomly assigned to one of two groups:

  • Group A: Home-based Kegel exercise program.
  • Group B: Supervised clinic-based pelvic floor rehabilitation program. Both interventions will be conducted over a 12-week period. Outcome Measures

The effectiveness of the interventions will be evaluated using:

  • Perineometer measurements to assess pelvic floor muscle strength.
  • Pad Test to assess urinary leakage severity.
  • King's Health Questionnaire (KHQ) to evaluate quality of life.
  • Adherence records to monitor compliance with the exercise program. Assessments will be conducted at baseline, week 8, and week 12. Data Analysis Data will be analyzed using SPSS software. Descriptive statistics, independent t-tests, Chi-square tests, and repeated-measures ANOVA will be used to compare outcomes between groups. Statistical significance will be set at p \< 0.05.

Ethical Considerations Ethical approval will be obtained prior to study commencement. Written informed consent will be obtained from all participants. Participation will be voluntary, confidentiality will be maintained, and participants will have the right to withdraw from the study at any time without affecting their healthcare services.

Expected Outcomes The study is expected to demonstrate improvements in pelvic floor muscle strength, urinary continence, and quality of life in both groups. The findings will provide evidence regarding whether home-based Kegel exercises can achieve outcomes comparable to supervised clinic-based rehabilitation, thereby informing future physiotherapy practice and healthcare policy.

Significance This research will contribute to the growing body of evidence on pelvic floor rehabilitation and may support the implementation of accessible, cost-effective, and evidence-based treatment options for women with urinary incontinence in Tabuk region in Saudi Arabia. The results may also guide clinicians and healthcare decision-makers in optimizing rehabilitation services and improving patient outcomes.

02

Conditions studied

  • Urinary Incontinence (UI)

Browse trials for

Keywords

  • Urinary incontinence, Pelvic floor muscles, Kegel Exrecises
03

In context

Urinary Incontinence

983 studies on the registry are indexed under Urinary Incontinence; 180 are open to participants now.

This study's planned enrollment of 100 is above the median of 66 across 739 interventional studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

University of Tabuk is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged 20-50 years.
  • Diagnosed with urinary incontinence.
  • Able to understand study instructions.
  • Willing to provide

Exclusion criteria

Exclusion Criteria:

  • Delivery within the previous 3 months.
  • Gynecological surgery during the previous 3 months.
  • Lower urinary tract surgery during the previous 3 months.
  • women.
  • to pelvic floor muscle training.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Home-Based Kegel Exercises

    Women diagnosed with urinary incontinence in this arm attending the Women's Department of Maternity and Children Hospital will use an AI trainer called Kegel trainer for 12 weeks focusing on strengthening the pelvic floor muscles. They will join a telegram group supervised by the caregiver to follow their interactions during the whole period.

    Other: Home -Based Kegel Trainer Exercises (Kegel Trainer Application) will be used by the participants at home for training the pelvic floor muscles over 9 levels.

  • Experimental
    Clinic-Based Rehabilitation Program

    Women diagnosed with urinary incontinence in this arm attending the Women's Department of Maternity and Children Hospital will be supervised by the Physiotherapist at the department for two times per week during the Kegel training for pelvic floor muscles training for 12 weeks .

    Other: Clinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months

Interventions

  • OtherHome -Based Kegel Trainer Exercises (Kegel Trainer Application) will be used by the participants at home for training the pelvic floor muscles over 9 levels.

    Kegel exercises are designed to focus on strengthening the weak pelvic floor muscles by using Kegel Trainer Application over 9 levels.

    Also known as: Kegel Trainer, Pelvic floor muscle exercises

  • OtherClinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months

    Clinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months

06

What researchers measure

Primary outcomes

  1. Perineometer

    Pelvic floor muscle strength will be measured using a perineometer min 0 cmH₂O and max 300 cmH₂O. Higher scores indicate greater pelvic floor muscle strength

    Time frame: From enrollment to the end of treatment at 12 weeks

Secondary outcomes

  1. long-term Pad Test

    Urinary leakage severity will be measured using the long-term Pad Test. Minimum value of 0 g. Higher values indicate greater urinary leakage and therefore worse urinary incontinence. Lower values indicate less urinary leakage and better outcome.

    Time frame: From enrollment to the end of treatment at 12 weeks

  2. King's Health Questionnaire

    • Quality of life will be measured using the King's Health Questionnaire with min score 0 and max score 100 for each domain. Lower scores indicate better quality of life.

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

1 site
  • Maternity and Children Hospital in Tabuk
    Tabuk, Tabuk Region, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
Aug 1, 2026→Oct 1, 2026
Sep 25, 2026
Primary completion
Jan 31, 2027→Feb 15, 2027
Sep 25, 2026
Study completion
Feb 28, 2027→Mar 1, 2027
Sep 25, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionPerineometer: how it is measured was reworded
Sep 25, 2026
Secondary outcomes
2 description edited
What changed in the outcomes
  • DescriptionKing's Health Questionnaire: how it is measured was reworded
  • Descriptionlong-term Pad Test: how it is measured was reworded
Sep 25, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Maternity and Children Hospital in Tabuk · Tabuk, Saudi ArabiaContact e•••@ut.edu.sa · •••6062→e•••@ut.edu.sa · •••6062
Sep 25, 2026
Title
A Comparison of Home-Based Kegel Exercises Versus Clinic-Based Kegel Rehabilitation in Women With Urinary Incontinence in the Tabuk Region: A Randomized Controlled Trial
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Start date Aug 1, 2026→Oct 1, 2026
    Primary completion Jan 31, 2027→Feb 15, 2027
    Study completion Feb 28, 2027→Mar 1, 2027
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionPerineometer: how it is measured was reworded
    Secondary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionKing's Health Questionnaire: how it is measured was reworded
    • Descriptionlong-term Pad Test: how it is measured was reworded
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Maternity and Children Hospital in Tabuk · Tabuk, Saudi ArabiaContact e•••@ut.edu.sa · •••6062→e•••@ut.edu.sa · •••6062
    Title A Comparison of Home-Based Kegel Exercises Versus Clinic-Based Kegel Rehabilitation in Women With Urinary Incontinence in the Tabuk Region: A Randomized Controlled Trial
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07795931
Lead sponsor
University of Tabuk
Responsible party
Enas Elsayed Mohamed Abutaleb (Associate Professor of Physical Therapy-University of Tabuk,Professor of Physical Therapy- Cairo University,, University of Tabuk) — Principal investigator
First posted
Aug 31, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Feb 15, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Sep 25, 2026

Study contacts

Enas ES Abutaleb, Associate Professor
principal investigator · University of Tabuk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion